Vital Therapies Inc (VTL)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Vital Therapies Inc (VTL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011445
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute liver failure by processing toxins and synthesizing proteins. Vital Therapies’s ELAD System contains immortal human liver-derived cells or VTL C3A cells that performs biochemical functions characteristic of human hepatocytes in in-vitro assays. Vital Therapies also provides programs for severe acute alcoholic hepatitis and alcohol induced liver decompensation, surgery-induced liver failure, fulminant liver failure, and chronic liver failure. It also conducts clinical trials. Vital Therapies is headquartered in San Diego, California, the US.

Vital Therapies Inc (VTL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vital Therapies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Vital Therapies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Vital Therapies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Vital Therapies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Vital Therapies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Vital Therapies Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Vital Therapies Raises US$12 Million In Venture Financing 10
Vital Therapies Raises US$2.5 Million In Venture Financing 11
Vital Therapies Secures USD4.35 Million in Venture Funding 12
Vital Therapies Secures US$22.6 Million In Financing 13
Equity Offering 14
Vital Therapies Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$62.1 Million 14
Acquisition 16
Jilin Aodong Medicine Completes Acquisition Of 2% Stake In Vital Therapies For US$2 Million 16
Vital Therapies Inc – Key Competitors 17
Vital Therapies Inc – Key Employees 18
Vital Therapies Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Oct 25, 2017: Vital Therapies Announces Third Quarter 2017 Financial Results 20
Aug 03, 2017: Vital Therapies Announces Second Quarter 2017 Financial Results 22
May 09, 2017: Vital Therapies Announces First Quarter 2017 Financial Results 23
Mar 07, 2017: Vital Therapies Announces Fourth Quarter and Full Year 2016 Financial Results 24
Nov 03, 2016: Vital Therapies Announces Third Quarter Financial Results 25
Aug 02, 2016: Vital Therapies Announces Second Quarter Financial Results 26
May 09, 2016: Vital Therapies Announces First Quarter Financial Results 27
Mar 08, 2016: Vital Therapies Announces Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update 28
Corporate Communications 30
Sep 06, 2017: Vital Therapies Appoints Former Receptos President and CEO Faheem Hasnain as Chairman of the Board of Directors 30
Aug 15, 2016: Vital Therapies Announces Appointment of Former Receptos President and CEO Faheem Hasnain to Its Board of Directors 31
Legal and Regulatory 32
Dec 11, 2017: Vital Therapies Added to NASDAQ Biotechnology Index 32
Other Significant Developments 33
Sep 13, 2016: Vital Therapies Provides Corporate Update 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Vital Therapies Inc, Medical Equipment, Key Facts, 2016 2
Vital Therapies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Vital Therapies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Vital Therapies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Vital Therapies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Vital Therapies Inc, Deals By Market, 2011 to YTD 2017 8
Vital Therapies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Vital Therapies Raises US$12 Million In Venture Financing 10
Vital Therapies Raises US$2.5 Million In Venture Financing 11
Vital Therapies Secures USD4.35 Million in Venture Funding 12
Vital Therapies Secures US$22.6 Million In Financing 13
Vital Therapies Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$62.1 Million 14
Jilin Aodong Medicine Completes Acquisition Of 2% Stake In Vital Therapies For US$2 Million 16
Vital Therapies Inc, Key Competitors 17
Vital Therapies Inc, Key Employees 18
Vital Therapies Inc, Subsidiaries 19

★海外企業調査レポート[Vital Therapies Inc (VTL)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oragenics Inc (OGEN)-製薬・医療分野:企業M&A・提携分析
    Summary Oragenics Inc (Oragenics) is a biopharmaceutical company that focuses on the development and commercialization of novel antibiotics against infectious disease and develops treatments for oral mucositis. The company develops a new class of potent gram-positive antibiotics which are called Lan …
  • Protege Energy III LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Protege Energy III LLC (Protege Energy) is an oil and gas exploration and production company. The company offers acquisition and development of oil and gas reserves including exploration, development, operations, horizontal drilling, reservoir stimulations, recompletions, artificial lift and …
  • Amatsigroup SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Amatsigroup SAS (Amatsigroup) is a contract development manufacturing organization that offers human and veterinary pharmaceutical development through preclinical and clinical phases. The organization provides services such as bioservices, clinical trial supply, formulation development and m …
  • DAMAC Real Estate Development Ltd:企業の戦略・SWOT・財務情報
    DAMAC Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report Summary DAMAC Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Kuros Biosciences AG (KURN):企業の製品パイプライン分析
    Summary Kuros Biosciences AG (Kuros Biosciences) is a developer of products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specifically fracture repair, as we …
  • LivaNova PLC (LIVN):製品パイプライン分析
    Summary LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery, neuromodulation and cardiac rhythm management. The company’s neuromodulation segment provides vagus nerve stimulation therapy system, an implantable device for the people affected by trea …
  • Jyske Bank A/S:企業の戦略・SWOT・財務情報
    Jyske Bank A/S - Strategy, SWOT and Corporate Finance Report Summary Jyske Bank A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • MS&AD Insurance Group Holdings, Inc.:企業のM&A・事業提携・投資動向
    MS&AD Insurance Group Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MS&AD Insurance Group Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Royal KPN N.V.:企業のM&A・事業提携・投資動向
    Royal KPN N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal KPN N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Trina Solar Co Ltd (688599):企業の財務・戦略的SWOT分析
    Trina Solar Co Ltd (688599) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Humanwell Healthcare (Group) Co Ltd (600079):医療機器:M&Aディール及び事業提携情報
    Summary Humanwell Healthcare (Group) Co Ltd (Humanwell), formerly Wuhan Humanwell Hi-Tech Industry Co Ltd is a pharmaceutical company that offers generic products. The company offers pharmaceutical, medical instrument and reproductive health care products and technologies. Its products include anest …
  • The Pep BoysManny, Moe & Jack:企業の戦略・SWOT・財務情報
    The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report Summary The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Suburban Propane Partners LP (SPH):企業の財務・戦略的SWOT分析
    Summary Suburban Propane Partners LP (Suburban Propane) distributes and markets energy-related products. The company supplies propane, fuel oil and refined fuels, and markets natural gas and electricity in deregulated markets. Suburban Propane also provides installation and service of various types …
  • Veolia Environnement SA (VIE):企業の財務・戦略的SWOT分析
    Veolia Environnement SA (VIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • DesignMedix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DesignMedix Inc (DesignMedix) is a biotechnology company that develop drugs to overcome drug resistance in multiple diseases such as malaria and diarrhea. The company develops malaria cure drugs, malaria preventive drugs and anti-bacterial drugs. It develops DM1157, a drug candidate that pro …
  • Verallia Deutschland AG:企業の戦略・SWOT・財務情報
    Verallia Deutschland AG - Strategy, SWOT and Corporate Finance Report Summary Verallia Deutschland AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Castlight Health Inc (CSLT):医療機器:M&Aディール及び事業提携情報
    Summary Castlight Health Inc (Castlight) provides an online health navigation platform that connects patients with health vendors, plan designs, and benefit resources. The platform allows patients to view and compare the prices of medical services and surgeries from multiple health providers. It off …
  • Granules India Ltd (GRANULES):製薬・医療:M&Aディール及び事業提携情報
    Summary Granules India Ltd (Granules) is a pharmaceutical manufacturing company, which carries out the research, development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs). The company manufactures Paracetomol, …
  • Smrt Corporation Ltd.
    Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SAcyr SA:企業の戦略・SWOT・財務情報
    SAcyr SA - Strategy, SWOT and Corporate Finance Report Summary SAcyr SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆